Elite Pharmaceuticals (ELTP) Net Income towards Common Stockholders (2010 - 2026)
Elite Pharmaceuticals (ELTP) posted Net Income towards Common Stockholders of $5.91 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$5.88 million a year earlier and down 68.0% from the prior quarter.
Elite Pharmaceuticals (ELTP) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Income towards Common Stockholders at Elite Pharmaceuticals was $56.67 million; for FY2026 (ended Mar 31, 2026), it was $44.87 million.
- Annual Net Income towards Common Stockholders shows a five-year compound annual growth rate of 54.6% (FY2021 to FY2026).
- In prior fiscal years, Elite Pharmaceuticals' Net Income towards Common Stockholders was -$4.31 million in FY2025, $20.11 million in FY2024 (+464.6%), $3.56 million in FY2023 (-60.0%) and $8.9 million in FY2022 (+74.9%).
- Quarterly Net Income towards Common Stockholders has run from a low of -$11.04 million in fiscal Q2 2025 to a high of $18.59 million in fiscal Q3 2026 over five years.
- The strongest year-over-year quarter for Net Income towards Common Stockholders in the past five years was fiscal Q2 2024, with growth of 577.8%; the weakest was fiscal Q1 2023, with a decline of 87.2%.
- According to Business Quant data, Net Income towards Common Stockholders for the three prior fiscal quarters was $18.46 million (Q4 2026), $18.59 million (Q3 2026) and $13.7 million (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Elite Pharmaceuticals | 269.28 Mn | 150.96 Mn | 13.51 Mn | 5.91 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.91 Mn |
| Mar 31, 2026 | 18.46 Mn |
| Dec 31, 2025 | 18.59 Mn |
| Sep 30, 2025 | 13.70 Mn |
| Jun 30, 2025 | -5.88 Mn |
| Mar 31, 2025 | 17.00 Mn |
| Dec 31, 2024 | -10.89 Mn |
| Sep 30, 2024 | -11.04 Mn |
| Jun 30, 2024 | 615,773.00 |
| Mar 31, 2024 | 3.33 Mn |
| Dec 31, 2023 | 706,354.00 |
| Sep 30, 2023 | 14.93 Mn |
| Jun 30, 2023 | 1.14 Mn |
| Mar 31, 2023 | -1.79 Mn |
| Dec 31, 2022 | 3.34 Mn |
| Sep 30, 2022 | 2.20 Mn |
| Jun 30, 2022 | 305,883.00 |
| Mar 31, 2022 | 2.43 Mn |
| Dec 31, 2021 | 2.28 Mn |
| Sep 30, 2021 | 1.80 Mn |
Elite Pharmaceuticals Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();